BAE Systems plc (BA.L)
GBp 1173.5
(0.3%)
GBp 1173.5
(0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.66 Billion | 2.69 Billion | 2.28 Billion | 985 Million | 1.53 Billion | 1.2 Billion |
| Net Income | 1.85 Billion | 1.59 Billion | 1.75 Billion | 1.29 Billion | 1.47 Billion | 1 Billion |
| Depreciation & Amortization | 787 Million | 764 Million | 701 Million | 671 Million | 604 Million | 277 Million |
| Deferred income taxes | -559 Million | -170 Million | -19 Million | -8 Million | 3 Million | -16 Million |
| Stock-based compensation | 110 Million | 101 Million | 92 Million | 74 Million | 74 Million | 64 Million |
| Change in working capital | 1.12 Billion | 323 Million | 49 Million | 146 Million | -299 Million | -773 Million |
| Other non-cash items | 344 Million | 87 Million | -301 Million | -1.19 Billion | -324 Million | 648 Million |
| Investing Cash Flow | -801 Million | -548 Million | -14 Million | -2.08 Billion | -402 Million | -358 Million |
| Investments in PPE | -957 Million | -693 Million | -462 Million | -477 Million | -470 Million | -358 Million |
| Acquisitions | -3 Million | -20 Million | 456 Million | -1.63 Billion | 64 Million | 77 Million |
| Investment purchases | - | -8 Million | -18 Million | -2 Million | -6 Million | -3 Million |
| Sales/Maturities of investments | - | 7 Million | - | 19 Million | - | -86 Million |
| Other Investing Activities | 159 Million | 166 Million | 10 Million | 10 Million | 10 Million | 12 Million |
| Financing Cash Flow | -1.83 Billion | -2.06 Billion | -1.99 Billion | 1.2 Billion | -1.73 Billion | -915 Million |
| Debt repayment | -162 Million | -400 Million | -367 Million | -2.16 Billion | -782 Million | -7 Million |
| Dividends payments | -857 Million | -802 Million | -777 Million | -746 Million | -724 Million | -703 Million |
| Common Stock Repurchased | -561 Million | -788 Million | -368 Million | -263 Million | - | - |
| Common Stock Issuance | -292 Million | -236 Million | -217 Million | 27 Million | - | 1 Million |
| Other Financing Activities | 40 Million | 162 Million | -262 Million | 4.34 Billion | -224 Million | -205 Million |
| Accounts receivables | -287 Million | -1.06 Billion | 610 Million | - | -481 Million | -757 Million |
| Accounts payables | 1.63 Billion | 1.48 Billion | -615 Million | 122 Million | 258 Million | 530 Million |
| Inventory | -223 Million | -93 Million | 54 Million | 24 Million | -76 Million | -16 Million |
| Other working capital | 1.63 Billion | - | 20 Million | 162 Million | - | -530 Million |
| Cash at beginning of period | 3.1 Billion | 2.91 Billion | 2.76 Billion | 2.58 Billion | 3.23 Billion | 3.26 Billion |
| Cash at end of period | 4.06 Billion | 3.1 Billion | 2.91 Billion | 2.76 Billion | 2.58 Billion | 3.23 Billion |
| Capital Expenditure | -957 Million | -693 Million | -462 Million | -477 Million | -470 Million | -358 Million |
| Effect of forex changes on cash | -71 Million | 106 Million | -7 Million | -22 Million | -48 Million | 41 Million |
| Net cash flow / Change in cash | 960 Million | 190 Million | 149 Million | 181 Million | -645 Million | -32 Million |
| Free Cash Flow | 2.7 Billion | 2 Billion | 1.81 Billion | 508 Million | 1.06 Billion | 842 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 948 Million | 892 Million | 1.85 Billion | 965 Million | 1.59 Billion | 976 Million |
| Depreciation & Amortization | 501 Million | 401 Million | 787 Million | 386 Million | 764 Million | 406 Million |
| Deferred income taxes | - | -334 Million | -559 Million | -673 Million | -170 Million | -170 Million |
| Stock-based compensation | 62 Million | 58 Million | 110 Million | 52 Million | 101 Million | 54 Million |
| Change in working capital | -728 Million | 974 Million | 1.12 Billion | 151 Million | 323 Million | 1.02 Billion |
| Other non-cash items | -26 Million | 62 Million | 344 Million | 616 Million | 87 Million | -205 Million |
| Investing Cash Flow | -4.56 Billion | -500 Million | -801 Million | -301 Million | -548 Million | -191 Million |
| Investments in PPE | -385 Million | -576 Million | -957 Million | -381 Million | -693 Million | -489 Million |
| Acquisitions | -4.53 Billion | -77 Million | -3 Million | 74 Million | -20 Million | 138 Million |
| Investment purchases | - | - | - | - | -8 Million | - |
| Sales/Maturities of investments | - | - | - | - | 7 Million | - |
| Other Investing Activities | 352 Million | 153 Million | 159 Million | 6 Million | 166 Million | 160 Million |
| Financing Cash Flow | 2.58 Billion | -791 Million | -1.83 Billion | -1.04 Billion | -2.06 Billion | -944 Million |
| Debt repayment | -3.64 Billion | -4 Million | -162 Million | -166 Million | -400 Million | - |
| Dividends payments | -562 Million | -349 Million | -857 Million | -508 Million | -802 Million | -322 Million |
| Common Stock Repurchased | -250 Million | -185 Million | -561 Million | -376 Million | -788 Million | -658 Million |
| Common Stock Issuance | - | -163 Million | -292 Million | -129 Million | -236 Million | - |
| Other Financing Activities | -253 Million | -90 Million | 40 Million | -194 Million | 162 Million | 130 Million |
| Accounts receivables | -558 Million | 181 Million | -287 Million | -468 Million | -1.06 Billion | -377 Million |
| Accounts payables | -65 Million | 902 Million | 1.63 Billion | 733 Million | 1.48 Billion | 1.41 Billion |
| Inventory | -170 Million | -109 Million | -223 Million | -114 Million | -93 Million | -19 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 4.06 Billion | 3.2 Billion | 3.1 Billion | 3.1 Billion | 2.91 Billion | 1.95 Billion |
| Cash at end of period | 2.83 Billion | 4.06 Billion | 4.06 Billion | 3.2 Billion | 3.1 Billion | 3.1 Billion |
| Capital Expenditure | -385 Million | -576 Million | -957 Million | -381 Million | -693 Million | -489 Million |
| Effect of forex changes on cash | -7 Million | -13 Million | -71 Million | -58 Million | 106 Million | 51 Million |
| Net cash flow / Change in cash | -1.23 Billion | 863 Million | 960 Million | 97 Million | 190 Million | 1.15 Billion |
| Free Cash Flow | 372 Million | 1.59 Billion | 2.7 Billion | 1.11 Billion | 2 Billion | 1.74 Billion |
CHMI-PA
SGQRF
PHARM
7942
ICCO
5254